Current Status of Serum Insulin and C-Peptide Measurement in Clinical Laboratories: Experience from 94 Laboratories in China
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Accurate measurements of serum insulin and C-peptide are needed for the therapy and classification of diabetes. This study investigated the status of serum insulin and C-peptide measurements in China by analyzing the results of five pooled serum samples measured in 94 laboratories. Methods: Patient serum samples were pooled into five groups according to insulin and C-peptide concentrations and measured in 94 laboratories using different measurement systems. The inter- and intra-laboratory %CV as well as inter- and intra-measurement system %CV were calculated to assess the status of insulin and C-peptide measurements. To verify whether the disagreement between laboratories was due to different calibrators, as reported in previous studies, one low-level and one high-level sample extracted from the five pooled serum samples were used to recalibrate clinical measurement systems. Results: The mean intra-laboratory, intra-measurement system, inter-laboratory, and inter-measurement system %CVs were 2.7%, 4.8%, 21.8%, and 22.4%, respectively, for insulin and 2.3%, 6.7%, 16.4%, and 24.5%, respectively, for C-peptide. The inter- and intra-laboratory %CVs for insulin decreased with increasing concentration. After recalibration with low- and high-level samples, the mean inter-measurement %CV decreased from 22.4% to 17.2% for insulin and from 24.5% to 5.7% for C-peptide. Conclusions: The intra-laboratory and intra-measurement system imprecision values are satisfactory for serum insulin and C-peptide measurements. However, the results from laboratories using different measurement systems were not comparable, and there is still much work needed to achieve the standardization or harmonization of serum insulin and C-peptide measurements.
Abstract
Background: Accurate measurements of serum insulin and C-peptide are needed for the therapy and classification of diabetes. This study investigated the status of serum insulin and C-peptide measurements in China by analyzing the results of five pooled serum samples measured in 94 laboratories. Methods: Patient serum samples were pooled into five groups according to insulin and C-peptide concentrations and measured in 94 laboratories using different measurement systems. The inter- and intra-laboratory %CV as well as inter- and intra-measurement system %CV were calculated to assess the status of insulin and C-peptide measurements. To verify whether the disagreement between laboratories was due to different calibrators, as reported in previous studies, one low-level and one high-level sample extracted from the five pooled serum samples were used to recalibrate clinical measurement systems. Results: The mean intra-laboratory, intra-measurement system, inter-laboratory, and inter-measurement system %CVs were 2.7%, 4.8%, 21.8%, and 22.4%, respectively, for insulin and 2.3%, 6.7%, 16.4%, and 24.5%, respectively, for C-peptide. The inter- and intra-laboratory %CVs for insulin decreased with increasing concentration. After recalibration with low- and high-level samples, the mean inter-measurement %CV decreased from 22.4% to 17.2% for insulin and from 24.5% to 5.7% for C-peptide. Conclusions: The intra-laboratory and intra-measurement system imprecision values are satisfactory for serum insulin and C-peptide measurements. However, the results from laboratories using different measurement systems were not comparable, and there is still much work needed to achieve the standardization or harmonization of serum insulin and C-peptide measurements.
참고문헌 (21)
- Zimmet P, "Diabetes mellitus statistics on prevalence and mortality : facts and fallacies", Nat Rev Endocrinol, 12, pp.616~622 (2016)
- Guariguata L, "Global estimates of diabetes prevalence for 2013 and projections for 2035", Diabetes Res Clin Pract, 103, pp.137~149 (2014)
- Leighton E, "A practical review of C-peptide testing in diabetes", Diabetes Ther, 8, pp.475~487 (2017)
- Jones AG, "The clinical utility of C-peptide measurement in the care of patients with diabetes", Diabet Med, 30, pp.803~817 (2013)
- Hörber S, "Harmonization of immunoassays for biomarkers in diabetes mellitus", Biotechnol Adv, 39, pp.107359~ (2020)
- Little RR, "Implementing a reference measurement system for C-peptide : successes and lessons learned", Clin Chem, 63, pp.1447~1456 (2017)
- Staten MA, "Insulin assay standardization : leading to measures of insulin sensitivity and secretion for practical clinical care", Diabetes Care, 33, pp.205~206 (2010)
- Manley SE, "Comparison of 11 human insulin assays : implications for clinical investigation and research", Clin Chem, 53, pp.922~932 (2007)
- Robbins DC, "Report of the American Diabetes Association’s Task Force on standardization of the insulin assay", Diabetes, 45, pp.242~256 (1996)
- Marcovina S, "Standardization of insulin immunoassays : report of the American Diabetes Association Workgroup", Clin Chem, 53, pp.711~716 (2007)
- Van Houcke SK, "Harmonization of immunoassays to the all-procedure trimmed mean-proof of concept by use of data from the insulin standardization project", Clin Chem Lab Med, 51, pp.e103~e105 (2013)
- Wiedmeyer HM, "International comparison of C-peptide measurements", Clin Chem, 53, pp.784~787 (2007)
- Miller WG, "Toward standardization of insulin immunoassays", Clin Chem, 55, pp.1011~1018 (2009)
- Little RR, "Standardization of C-peptide measurements", Clin Chem, 54, pp.1023~1026 (2008)
- Ricós C, "Current databases on biological variation: pros, cons and progress", Scand J Clin Lab Invest, 59, pp.491~500 (1999)
- Moore M, "Preparation, calibration and evaluation of the First International Standard for human C-peptide", Clin Chem Lab Med, 55, pp.1224~1233 (2017)
- Kinumi T, "Quantification of serum C-peptide by isotope-dilution liquid chromatography-tandem mass spectrometry : enhanced detection using chemical modification and immunoaffinity purification", J Chromatogr B Analyt Technol Biomed Life Sci, 953-954, pp.138~142 (2014)
- Kinumi T, "Development of SI-traceable C-peptide certified reference material NMIJ CRM 6901-a using isotope-dilution mass spectrometry-based amino acid analyses", Anal Bioanal Chem, 404, pp.13~21 (2012)
- Stoyanov AV, "Use of cation exchange chromatography for human C-peptide isotope dilution-mass spectrometric assay", J Chromatogr A, 1218, pp.9244~9249 (2011)
- "2021 C-Peptide Standardization Manufacturer Meeting Minutes" (2022)[URL]
- Rodríguez-Cabaleiro D, "Pilot study for the standardization of insulin immunoassays with isotope dilution liquid chromatography", tandem mass spectrometry, 2007, pp.53, 1462~1469